Supriya Lifescience Ltd

NSE: SUPRIYA · BSE: 543434 · Pharmaceuticals & Biotechnology · 12 announcements

Share price: ₹985.20
Market cap: ₹7,929 Cr
Revenue (annual): ₹827.9 Cr
Net profit (annual): ₹209.1 Cr
P/E (TTM): 40.0×Sector 50.4×
Promoter holding: 68.30%+0.00% QoQ
FII holding: 6.18%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Legal & Regulatory 2 Financial Results 2 Results Correction 1 Other Announcement 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

23 Sep 2026 11:32 IST BSE

Legal & Regulatory

Supriya Lifescience Legal & Regulatory

Bombay High Court ordered provisional release of 200 kg Ketamine Hydrochloride consignment subject to ₹0.72 Crore deposit. Criminal and NDPS proceedings continue.

Value: ₹0.72 Cr

Read the filing ↗

2 Sep 2026 17:32 IST NSE

Legal & Regulatory

Supriya Lifescience Legal & Regulatory

Supriya Lifescience Limited informed stock exchanges that there have been no new developments regarding ongoing judicial proceedings involving its General Manager.

Read the filing ↗